Real-world cardiovascular assessment of mirabegron treatment in patients with overactive bladder and concomitant cardiovascular disease: results of a Japanese post-marketing study

Research Type

Clinical

Abstract Category

Overactive Bladder

Links
	Abstract 118
	Open Discussion ePosters Scientific Open Discussion Session 7
	Wednesday 14th September 2016
	12:40 - 12:45 (ePoster Station 5)
	ePoster Area
	Overactive Bladder Prospective Study Urgency/Frequency
	1. Astellas Pharma Inc, 2. Cardiovascular Centre, International University of Health and Welfare, Mita Hospital, Tokyo, Japan
Presenter
D Daisuke Kato Astellas Pharma Inc
Abstract PDF Edit Abstract Abstract Centre